Description

6-Chloro-7-Cyclobutyl-3-(2,6-Difluorophenyl)-[1,2,4]Triazolo[4,3-B]Pyridazine is a high-value, heterocyclic organic compound featuring a fused triazolopyridazine core, designed for advanced research and development. This molecule is of significant interest due to its complex structure, which serves as a key pharmacophore and building block in medicinal chemistry. It is primarily sought after by pharmaceutical R&D teams and fine chemical manufacturers for the synthesis of novel active pharmaceutical ingredients (APIs) and agrochemicals.

Application

• Pharmaceutical Intermediate: A critical building block in the research and synthesis of new drug candidates, particularly in oncology, neurology, and anti-inflammatory therapeutic areas.
• Agrochemical Research: Used in the development of next-generation herbicides, fungicides, and pesticides, leveraging its heterocyclic scaffold for biological activity.
• Chemical Biology Probe: Serves as a specialized molecular tool for studying enzyme inhibition, receptor binding, and other biochemical pathways in academic and industrial research.
• Material Science Precursor: Potential use in the synthesis of advanced organic materials, such as ligands for catalysts or components in organic electronics.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for the production of bespoke compounds and scaled-up processes.

Basic Information

Product Name	6-Chloro-7-Cyclobutyl-3-(2,6-Difluorophenyl)-[1,2,4]Triazolo[4,3-B]Pyridazine
CAS No.	1351952-76-5
Molecular Formula	C₁₇H₁₂ClF₂N₅
Molecular Weight	359.76 g/mol
Synonyms	6-Chloro-7-cyclobutyl-3-(2,6-difluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine; 6-Chloro-7-cyclobutyl-3-(2,6-difluorophenyl)-s-triazolo[4,3-b]pyridazine; [1,2,4]Triazolo[4,3-b]pyridazine, 6-chloro-7-cyclobutyl-3-(2,6-difluorophenyl)-; 1351952-76-5; 6-Chloro-7-cyclobutyl-3-(2,6-difluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine; Triazolopyridazine derivative CAS 1351952-76-5
EINECS	Contact for details

Quality Control

Our production of 6-Chloro-7-Cyclobutyl-3-(2,6-Difluorophenyl)-[1,2,4]Triazolo[4,3-B]Pyridazine adheres to stringent quality management protocols to ensure batch-to-batch consistency and high purity. Each lot is characterized and tested using advanced analytical techniques including HPLC, NMR, and MS. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound is light-sensitive; prolonged exposure to light should be avoided to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC/MS)	Conforms
Purity (HPLC)	≥ 97.0%
Single Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.